RUNX1 Research Program

We are a research and advocacy venture committed to funding world-class, innovative and cross-disciplinary cancer research to find a cure for those with the germline RUNX1mutation, a familial platelet disorder with a predisposition to leukemia (RUNX1 FPD, otherwise known as FPD/AML or FPD/MM). The program also aims to support, inform, educate and connect patients and healthcare providers in the RUNX1 community.